Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/2014
12/04/2014US20140356281 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17
12/02/2014USRE45272 β-glucuronide-linker drug conjugates
12/02/2014US8901283 Anti-NKG2A antibodies and uses thereof
12/02/2014US8901282 Reagents and methods for detecting a polymorphic protein
12/02/2014US8901281 ILT3 binding molecules and uses therefor
12/02/2014US8901280 Antibody against RGD in amino acid sequence of extracellular matrix protein and production method and use of the same
12/02/2014US8901279 Humanized antibodies with anti-tumor activity
12/02/2014US8901278 Pharmaceutical antibody compositions with resistance to soluble CEA
12/02/2014US8901099 Method for immunizing animal, composition for immunization, method for producing antibody, method for producing hybridoma, and method for producing monoclonal antibody
12/02/2014US8901045 Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries
12/02/2014US8901017 Formaldehyde-free proteinaceous binder compositions
12/02/2014US8900826 Glycoprotein synthesis and remodeling by enzymatic transglycosylation
12/02/2014US8900825 Immunogenic proteins of Leptospira
12/02/2014US8900823 Binding partners for the thyrotropin receptor and uses thereof
12/02/2014US8900819 ADRB2 cancer markers
12/02/2014US8900806 Antibody preparations
12/02/2014US8900597 Compositions relating to a mutant Clostridium difficile toxin and methods thereof
12/02/2014US8900596 Physicochemical (PCP) based consensus sequences and uses thereof
12/02/2014US8900592 Protein constructs designed for targeting and lysis of cells
12/02/2014US8900590 Anti-hemagglutinin antibody compositions and methods of use thereof
12/02/2014US8900589 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
12/02/2014US8900588 Methods for treating breast cancer
12/02/2014US8900587 Antibodies to human programmed death receptor PD-1
12/02/2014US8900586 Antibody that binds domain 2 of ICAM-1 and methods of treatment
12/02/2014US8900585 Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection
12/02/2014US8900584 Human CDR-grafted antibody and antibody fragment thereof
12/02/2014US8900583 Methods for treatment of brain injury utilizing biologics
12/02/2014US8900582 Deimmunized anti c-Met humanized antibodies and uses thereof
12/02/2014US8900579 Siglec-15 antibodies in treating bone loss-related disease
12/02/2014US8900578 Anti-IL-TIF antibodies
12/02/2014US8900577 Immunoglobulin formulation and method of preparation thereof
11/2014
11/27/2014US20140351960 Artery- and vein-specific proteins and uses therefor
11/27/2014US20140350226 Rspondins as modulators of angiogenesis and vasculogenesis
11/27/2014US20140350225 Anti-bfgf humanized double-stranded antibody with stable disulfide bond, preparation method and application thereof
11/27/2014US20140349946 Peptides derived from human bplp protein, polynucleotides coding for said peptides and antibodies directed against said peptides
11/27/2014US20140349893 Labeling of immobilized proteins using dipyrrometheneboron difluoride dyes
11/27/2014US20140349399 Compositions and Methods for Diagnosing and Treating Cancer
11/27/2014US20140349395 Anti-cd40 antibodies and methods of use
11/27/2014US20140349371 Protein Refolding Method
11/27/2014US20140349342 Interleukin-6 receptor binding polypeptides
11/27/2014US20140349341 Production of recombinant proteins with simple glycoforms
11/27/2014US20140349323 Anti-drug antibody assay
11/27/2014US20140349321 Binding molecules against dengue virus and uses thereof
11/27/2014US20140349319 Antibody specific for trans-resveratrol and use thereof
11/27/2014US20140349277 Anti-human norovirus gii antibody
11/27/2014US20140348935 TREATMENT OF FOOD INTOLERANCE AND FOOD ALLERGY WITH IgA
11/27/2014US20140348923 Polymeric Drug-Delivery Material, Method For Manufacturing Thereof And Method For Delivery Of A Drug-Delivery Composition
11/27/2014US20140348889 Compositions and Methods for Treating and Preventing Neointimal Stenosis
11/27/2014US20140348867 Isolated Brachyspira and Methods and Compositions for Expanding and Isolating Brachyspira
11/27/2014US20140348866 Gb virus c (hepatitis g virus) for the treatment of hiv
11/27/2014US20140348858 Monoclonal antibodies specific for the m2-1 antigen of respiratory syncytial virus (rsv)
11/27/2014US20140348857 Methods of diagnosis and treatment of endoplasmic reticulum (er) stress-related conditions
11/27/2014US20140348856 Il-17 binding proteins
11/27/2014US20140348855 Antibody formulations
11/27/2014US20140348854 HE4 Based Therapy For Malignant Disease
11/27/2014US20140348852 Method for making precipitated particles
11/27/2014US20140348851 Antibodies directed against influenza
11/27/2014US20140348850 Method for reducing blood pressure using inhibitors of plasma kallikrein
11/27/2014US20140348849 Compounds and Method for Modulating Inflammatory Reactions
11/27/2014US20140348848 Anti-il-1beta (interleukin-1beta) antibody-based prophylactic therapy to prevent complications leading to vaso-occlusion in sickle cell disease
11/27/2014US20140348847 Antibodies against human il-12
11/27/2014US20140348846 Anti-hla class-ib antibodies mimic immunoreactivity and immunomodulatory functions of intravenous immunoglobulin (ivig) useful as therapeutic ivig mimetics and methods of their use
11/27/2014US20140348845 Ion exchange membrane chromatography
11/27/2014US20140348844 Neutralising antibodies to the major exotoxins tcda and tcdb of clostridium difficile
11/27/2014US20140348843 Apoe immunotherapy
11/27/2014US20140348842 Tim-3 ligands and methods thereof
11/27/2014US20140348841 Anti-gitr antibodies
11/27/2014US20140348839 Modified polypeptides for bispecific antibody scaffolds
11/27/2014US20140348838 Il-1 binding proteins
11/27/2014US20140348837 Binding molecules for bcma and cd3
11/27/2014US20140348836 Anti-cd40 antibodies, uses and methods
11/27/2014US20140348835 Anti-dll4/vegf dual variable domain immunoglobulin and uses thereof
11/27/2014US20140348834 Il-17 binding proteins
11/27/2014US20140348833 Novel methods and antibodies for treating cancer
11/27/2014US20140348832 Inhibitors of t-cell activation
11/27/2014US20140348831 Anti-prostate cancer antibodies and methods of detection and treatment of prostate cancer using the same
11/27/2014US20140348830 Interleukin-6 receptor binding polypeptides
11/27/2014US20140348829 Felinized Antibodies and Methods of Treating Retroviral Infections in Felines
11/27/2014US20140348822 Methods and Compositions to Treat and Detect Misfolded-SOD1 Mediated DIseases
11/27/2014US20140348821 Defective Mismatch Repair and Benefit from Bevacizumab for Colon Cancer
11/27/2014US20140348820 Immunoglobulins with reduced aggregation
11/27/2014US20140348818 Biomarkers of kawasaki disease
11/27/2014US20140348798 Seneca valley virus based compositions and methods for treating disease
11/27/2014US20140348785 Neutralizing gp41 antibodies and their use
11/27/2014US20140348784 Compositions and methods for treatment of angiogenesis in pathological lesions
11/27/2014US20140348762 Diagnostic methods
11/27/2014US20140348745 Chimeric therapeutic anti - cd37 antibodie hh1
11/27/2014US20140348744 Compositions and methods for regulating cancer-related signaling pathways
11/27/2014US20140348743 Monoclonal antibodies to programmed death 1 (pd-1)
11/25/2014US8895714 Biological products
11/25/2014US8895713 Clostridial neurotoxins with altered persistency
11/25/2014US8895710 Chromatography ligand
11/25/2014US8895709 Isolation and purification of antibodies using protein A affinity chromatography
11/25/2014US8895705 Antibodies against a proliferating inducing ligand (APRIL) and methods of use thereof
11/25/2014US8895704 High affinity antibodies that neutralize Staphylococcus enterotoxin B
11/25/2014US8895703 CA125 gene and its use for diagnostic and therapeutic interventions
11/25/2014US8895702 Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodies
11/25/2014US8895701 Peptide-conjugated oligonucleotide therapeutic and method of making and using same
11/25/2014US8895698 Binding partners of antibodies specific for dendritic cell antigens
11/25/2014US8895475 Focused libraries of genetic packages
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 1494